|
|
Volumn 28, Issue 11, 2010, Pages 1143-
|
|
News maker: Anaphore
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
INTERLEUKIN 23 RECEPTOR;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
TETRANECTIN;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;
RECOMBINANT PROTEIN;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUG MARKETING;
FUNDING;
HUMAN;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DOMAIN;
PROTEIN ENGINEERING;
PROTEIN FUNCTION;
PROTEIN STRUCTURE;
ANIMAL;
CHEMISTRY;
CLINICAL TRIAL (TOPIC);
ECONOMICS;
MOUSE;
ANIMALS;
BIOTECHNOLOGY;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HUMANS;
MICE;
PROTEIN ENGINEERING;
RECOMBINANT PROTEINS;
|
|
EID: 78149310363
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1110-1143 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
